Abilify MyCite Interactions
There are 732 drugs known to interact with Abilify MyCite (aripiprazole), along with 17 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 65 are major, 663 are moderate, and 4 are minor.
- View all 732 medications that may interact with Abilify MyCite
- View Abilify MyCite alcohol/food interactions (4)
- View Abilify MyCite disease interactions (17)
Most frequently checked interactions
View interaction reports for Abilify MyCite (aripiprazole) and the medicines listed below.
- acetaminophen
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall XR (amphetamine / dextroamphetamine)
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- amlodipine
- atorvastatin
- azithromycin
- clonazepam
- Depakote (divalproex sodium)
- divalproex sodium
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydroxyzine
- Invega Trinza (paliperidone)
- Lamictal (lamotrigine)
- lamotrigine
- lansoprazole
- Latuda (lurasidone)
- lisinopril
- paliperidone
- Topamax (topiramate)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vraylar (cariprazine)
- Zyprexa Zydis (olanzapine)
Abilify MyCite alcohol/food interactions
There are 4 alcohol/food interactions with Abilify MyCite (aripiprazole).
Abilify MyCite disease interactions
There are 17 disease interactions with Abilify MyCite (aripiprazole) which include:
- suicidality
- dementia
- acute alcohol intoxication
- CNS depression
- NMS
- aspiration
- seizure
- hematologic abnormalities
- hyperglycemia/diabetes
- hypotension
- lipid alterations
- weight gain
- anticholinergic effects
- hyperprolactinemia
- liver disease
- parkinsonism
- tardive dyskinesia
Report options
More about Abilify MyCite (aripiprazole)
- Abilify MyCite consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rexulti
Rexulti (brexpiprazole) is a prescription antipsychotic medication used in the treatment of major ...
Vraylar
Vraylar is a once a day antipsychotic medication used to treat mental health or mood disorders ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Lexapro
Lexapro is used to treat anxiety and major depressive disorder. Learn about side effects ...
Abilify
Abilify is an antipsychotic medicine used to treat the symptoms of schizophrenia and bipolar ...
Zoloft
Zoloft is an antidepressant used to treat major depression, obsessive-compulsive disorder, panic ...
Risperidone
Risperidone is used to treat schizophrenia and symptoms of bipolar disorder. Learn about side ...
Citalopram
Citalopram is an antidepressant (selective serotonin reuptake inhibitor) and is used to treat ...
Olanzapine
Olanzapine (brand name Zyprexa) is an atypical antipsychotic that may be used to treat adults and ...
Quetiapine
Quetiapine is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and major ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
